Delivery Order SPE2DB20D9127-SPE2DB25FPPY0
Award Date
2/26/25
Potential Completion Date
3/19/25
Potential Value
$32K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $51,581.80, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of TYSABRI 300 MG/15 ML VIAL 15ML, a specialized pharmaceutical product. The contract has an ultimate completion date of April 1, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $41,265.44 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Tysabri 300 mg/15 ml vials over a period ending on May 15, 2024. This delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,037.12 firm fixed-price delivery order is for the product "TYSABRI 300 MG/15 ML VIAL 15ML" and has an ultimate completion date of February 10, 2023. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $121,637.40 firm fixed-price delivery order is for the provision of Tysabri 300 mg/15 ml vials. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $10,316.36 firm fixed-price delivery order contract is for the supply of TYSABRI 300 MG/15 ML VIAL 15ML, a pharmaceutical product. The contract has an ultimate completion date of April 15, 2024 and does not have a set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $52,912.40 firm fixed-price delivery order is for the provision of TYSABRI 300 MG/15 ML VIAL 15ML, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program....
This federal contract award was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,316.36 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product TYSABRI 300 MG/15 ML VIAL 15ML. The contract does not have a set-aside designation and is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $42,679.70 firm fixed-price delivery order is for the provision of 4555962979 TYSABRI 300 MG/15 ML VIAL 15ML, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order valued at $5,158.18, is for the supply of the biologic drug TYSABRI 300 MG/15 ML VIAL 15ML. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, which has a ceiling value of up to $499,999,999 and...
The federal contract award SPE2DB22D9316|SPE2DB25FYM60, valued at $5,158.18, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the product "TYSABRI 300 MG/15 ML VIAL 15ML" and has an ultimate completion date of December 6, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply...